Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to evaluate whether the investigational drug ganaxolone
can help smokers quit smoking. Ganaxolone is a drug that has been investigated (in other
research studies) for the treatment of seizures and migraines. This drug is considered
investigational in the US.